Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth L Masters

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
Cell Metabolism|April 24, 2018
Evidence that TLR4 Is Not a Receptor for Saturated Fatty Acids but Mediates Lipid-Induced Inflammation by Reprogramming Macrophage MetabolismGraeme I Lancaster, Katherine G Langley, Nils Anton Berglund, et al.
Cell Metabolism|November 26, 2015
IL-18 Production from the NLRP1 Inflammasome Prevents Obesity and Metabolic SyndromeAndrew J Murphy, Michael J Kraakman, Helene L Kammoun, et al.
Nature Immunology|September 14, 2010
Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetesSeth L Masters, Aisling Dunne, Shoba L Subramanian, et al.
The Journal of Allergy and Clinical Immunology|September 17, 2020
Excessive deubiquitination of NLRP3-R779C variant contributes to very-early-onset inflammatory bowel disease developmentLingli Zhou, Tao Liu, Bing Huang, et al.
Nature Microbiology|January 14, 2017
EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammationJaclyn S Pearson, Cristina Giogha, Sabrina Mühlen, et al.
Nature Microbiology|February 14, 2017
Erratum: EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammationJaclyn S Pearson, Cristina Giogha, Sabrina Mühlen, et al.
Nature Medicine|February 17, 2015
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseasesRebecca C Coll, Avril A B Robertson, Jae Jin Chae, et al.
The New England Journal of Medicine|September 7, 2007
STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosusElaine F Remmers, Robert M Plenge, Annette T Lee, et al.
Cell|October 8, 2020
TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALSChien-Hsiung Yu, Sophia Davidson, Cassandra R Harapas, et al.
Science (New York, N.Y.)|July 20, 2022
ZAKα-driven ribotoxic stress response activates the human NLRP1 inflammasomeKim S Robinson, Gee Ann Toh, Pritisha Rozario, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Cell Metabolism|April 24, 2018
Evidence that TLR4 Is Not a Receptor for Saturated Fatty Acids but Mediates Lipid-Induced Inflammation by Reprogramming Macrophage MetabolismGraeme I Lancaster, Katherine G Langley, Nils Anton Berglund, et al.
Cell Metabolism|November 26, 2015
IL-18 Production from the NLRP1 Inflammasome Prevents Obesity and Metabolic SyndromeAndrew J Murphy, Michael J Kraakman, Helene L Kammoun, et al.
Nature Immunology|September 14, 2010
Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetesSeth L Masters, Aisling Dunne, Shoba L Subramanian, et al.
The Journal of Allergy and Clinical Immunology|September 17, 2020
Excessive deubiquitination of NLRP3-R779C variant contributes to very-early-onset inflammatory bowel disease developmentLingli Zhou, Tao Liu, Bing Huang, et al.
Nature Microbiology|January 14, 2017
EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammationJaclyn S Pearson, Cristina Giogha, Sabrina Mühlen, et al.
Nature Microbiology|February 14, 2017
Erratum: EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammationJaclyn S Pearson, Cristina Giogha, Sabrina Mühlen, et al.
Nature Medicine|February 17, 2015
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseasesRebecca C Coll, Avril A B Robertson, Jae Jin Chae, et al.
The New England Journal of Medicine|September 7, 2007
STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosusElaine F Remmers, Robert M Plenge, Annette T Lee, et al.
Cell|October 8, 2020
TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALSChien-Hsiung Yu, Sophia Davidson, Cassandra R Harapas, et al.
Science (New York, N.Y.)|July 20, 2022
ZAKα-driven ribotoxic stress response activates the human NLRP1 inflammasomeKim S Robinson, Gee Ann Toh, Pritisha Rozario, et al.
Pageof 14